Sientra CEO on Resilient Growth, Pushing the Field of Plastic Surgery Forward
By Alan Hatfield Sientra, Inc. (Nasdaq: SIEN) is a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery. IPO...
Muscle Maker Plans $20 Million Reg A+ IPO, NYSE Listing Under Ticker “MMB”
Healthy-inspired restaurant chain Muscle Maker plans to raise up to $20 million in a Reg...
Electric-Vehicle Technology Firm Adomani Prices S-1 Secondary Offering, A First for Reg A+ Issuer
Adomani (ticker: ADOM) priced an $11 million secondary offering under normal S-1 rules, the first...
Canadian Cannabis Company Gets SEC Approval for Reg A+ Offering in U.S.
Canada’s True Leaf Medicine (tickers: CSE:MJ; OTCQB:TRLFF) received SEC approval for a Reg A+ offering,...
Myomo Reg A+ IPO Profiled in WSJ, Showing Path That Mirrors Most Traditional IPOs
This article in The Wall Street Journal follows the path of medical-robotics maker Myomo (ticker:...
Here’s How Reg A+ May Help Businesses Pursue Initial Coin Offerings
Initial coin offerings (ICOs) may find precisely the regulatory structure they need by filing under...
TerraCycle Offers Reg A+ Deal For Investors in Futuristic Recycling Business
In this Bloomberg article, the founder of a startup called TerraCycle explains how he can...
Academic Predicts Reg A+ Will Complement, Not Substitute Traditional IPOs
Reg A+ IPOs are likely to complement but not replace traditional IPOs even as they...
